14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ACAD stock ended at $17.05. This is 0.176% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.25% from a day low at $17.03 to a day high of $17.58.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jun 18, 2020 $46.93 $50.19 $46.49 $49.32 1 512 422
Jun 17, 2020 $47.84 $48.00 $46.49 $47.12 599 750
Jun 16, 2020 $47.51 $47.94 $46.44 $47.34 775 081
Jun 15, 2020 $44.90 $46.88 $44.55 $46.49 929 536
Jun 12, 2020 $46.00 $46.21 $44.46 $45.85 1 103 189
Jun 11, 2020 $46.35 $46.72 $45.15 $45.19 988 657
Jun 10, 2020 $47.92 $48.65 $46.56 $47.02 774 408
Jun 09, 2020 $46.82 $48.21 $46.25 $47.49 937 500
Jun 08, 2020 $45.45 $47.21 $44.70 $46.81 1 052 504
Jun 05, 2020 $45.78 $46.58 $45.13 $45.61 847 920
Jun 04, 2020 $46.55 $47.79 $45.02 $45.75 1 167 967
Jun 03, 2020 $48.27 $48.36 $46.32 $46.90 1 163 884
Jun 02, 2020 $49.01 $49.01 $47.37 $48.02 1 049 841
Jun 01, 2020 $49.47 $50.39 $48.69 $48.89 1 209 187
May 29, 2020 $51.01 $51.32 $48.00 $49.68 1 196 470
May 28, 2020 $51.10 $52.27 $49.88 $50.69 1 014 440
May 27, 2020 $51.58 $52.06 $48.25 $50.63 1 048 300
May 26, 2020 $51.94 $53.05 $51.10 $51.17 1 144 889
May 22, 2020 $51.59 $51.61 $50.45 $51.24 420 063
May 21, 2020 $52.58 $52.97 $51.05 $51.57 652 726
May 20, 2020 $51.45 $52.80 $50.86 $52.55 814 705
May 19, 2020 $51.93 $53.13 $50.98 $51.04 858 851
May 18, 2020 $51.45 $52.83 $51.16 $52.06 1 317 671
May 15, 2020 $47.45 $50.85 $46.99 $50.83 1 242 464
May 14, 2020 $45.33 $47.63 $44.66 $47.36 1 582 246
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT